136 related articles for article (PubMed ID: 14583429)
1. Visual vignette. Cabergoline therapy.
Stanciu I; Gordon DL
Endocr Pract; 2003; 9(5):475. PubMed ID: 14583429
[No Abstract] [Full Text] [Related]
2. Pons herniation into skull base after cabergoline therapy of giant prolactinoma.
Moles Herbera J; Rivero Celada D; Montejo Gañan I; Fustero de Miguel D; Fuentes Uliaque C; Vela Marín AC
Pituitary; 2015 Feb; 18(1):68-71. PubMed ID: 24522845
[TBL] [Abstract][Full Text] [Related]
3. Resolution of third nerve palsy following treatment of prolactinoma with cabergoline.
Harries AM; Gittoes NJ; Mitchell RD
Acta Neurochir (Wien); 2010 Oct; 152(10):1741-3. PubMed ID: 20623359
[TBL] [Abstract][Full Text] [Related]
4. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
Delgrange E; Maiter D; Donckier J
Eur J Endocrinol; 1996 Apr; 134(4):454-6. PubMed ID: 8640297
[TBL] [Abstract][Full Text] [Related]
5. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].
Castro-Castro J; Torre-Eiriz JA; Pinzón-Millán A; Pastor-Zapata A
Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286
[TBL] [Abstract][Full Text] [Related]
6. Giant pubertal prolactinoma: Complete resolution following short term carbegoline treatment.
Oguz A; Tuzun D; Sahin M; Gul K
Niger J Clin Pract; 2016; 19(5):685-7. PubMed ID: 27538562
[TBL] [Abstract][Full Text] [Related]
7. Cabergoline treatment in a case of macroprolactinoma after delivery.
Falsetti L
Acta Eur Fertil; 1995; 26(3):105-7. PubMed ID: 9098469
[TBL] [Abstract][Full Text] [Related]
8. Toward the establishment of a clinical prediction rule for response of prolactinomas to cabergoline.
Delgrange E; Donckier JE
J Clin Endocrinol Metab; 1999 Dec; 84(12):4746-7. PubMed ID: 10599747
[No Abstract] [Full Text] [Related]
9. Pituitary apoplexy associated with cabergoline therapy.
Chng E; Dalan R
J Clin Neurosci; 2013 Dec; 20(12):1637-43. PubMed ID: 24113159
[TBL] [Abstract][Full Text] [Related]
10. Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Delgrange E; Donckier J
J Clin Endocrinol Metab; 1997 Aug; 82(8):2755-6. PubMed ID: 9253367
[No Abstract] [Full Text] [Related]
11. Impressive shrinkage of a giant prolactinoma treated with cabergoline in a prepubescent girl. What now?
Christoforidis A; Tsakalides C; Anastasiou A; Pavlaki A; Dimitriadou M
Neuro Endocrinol Lett; 2013; 34(4):275-7. PubMed ID: 23803868
[TBL] [Abstract][Full Text] [Related]
12. Serial 3 T magnetic resonance imaging during cabergoline treatment of macroprolactinomas.
Kurosaki M; Kambe A; Watanabe T; Fujii S; Ogawa T
Neurol Res; 2015 Apr; 37(4):341-6. PubMed ID: 25376133
[TBL] [Abstract][Full Text] [Related]
13. Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma.
Marcos L; De Luis DA; Botella I; Hurtado A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):126-7. PubMed ID: 11167937
[No Abstract] [Full Text] [Related]
14. Treatment of macroprolactinoma with cabergoline: a study of 85 patients.
Ferrari CI; Abs R; Bevan JS; Brabant G; Ciccarelli E; Motta T; Mucci M; Muratori M; Musatti L; Verbessem G; Scanlon MF
Clin Endocrinol (Oxf); 1997 Apr; 46(4):409-13. PubMed ID: 9196602
[TBL] [Abstract][Full Text] [Related]
15. Toward the establishment of a clinical prediction rule for response of prolactinomas to cabergoline.
Verhelst JA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4747. PubMed ID: 10599748
[No Abstract] [Full Text] [Related]
16. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
Dhanwal DK; Sharma AK
Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
[TBL] [Abstract][Full Text] [Related]
17. Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
Dash S; Annamalai AK; Simpson HL; Sarkies N; Antoun NM; Mannion R
QJM; 2013 Jan; 106(1):85. PubMed ID: 22075008
[No Abstract] [Full Text] [Related]
18. Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Colao A; Lombardi G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2756. PubMed ID: 9253368
[No Abstract] [Full Text] [Related]
19. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
Kawabata Y; Ueno Y; Horikawa F; Miyake H; Miki N; Ono M
Surg Neurol; 2008 Jan; 69(1):85-8; discussion 88. PubMed ID: 17967478
[TBL] [Abstract][Full Text] [Related]
20. Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers.
Mallea-Gil MS; Cristina C; Perez-Millan MI; Villafañe AM; Ballarino C; Stalldecker G; Becu-Villalobos D
Endocr Pathol; 2009; 20(1):35-40. PubMed ID: 19172414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
